Gregg Weiner
Professional Bio
Gregg is co-chair of the firm's Litigation and Enforcement practice group, based in Ropes & Gray’s New York office. Gregg has over 25 years of experience delivering successful results to financial institutions, Fortune 500 companies, professional services organizations, hedge funds and other sophisticated clients in a wide range of complex commercial disputes. His practice involves matters concerning the federal securities laws, commercial contracts, financial transactions/instruments, corporate governance, breach of fiduciary duty claims and mergers and acquisitions. Gregg also frequently represents real estate developers, investors and owners in high-profile litigation matters.
S.D.N.Y. Dismisses Investor Suit Concerning Pancreatic Cancer Drug Study
Life Sciences Securities Litigation ·
NERA Report Shows Continued Focus of Plaintiffs’ Securities Bar on the Pharmaceutical Industry
Life Sciences Securities Litigation ·
District Judge Dismisses Securities Class Action Against Novan, Inc. Relating To Disclosure of FDA Recommendations About Clinical Trials
Life Sciences Securities Litigation ·
S.D.N.Y. Partially Dismisses Shareholder Class Action Claims Based on Pharmaceutical Company’s Nonactionable Statements of Opinion
Life Sciences Securities Litigation ·
Unanimous Sixth Circuit Reverses Dismissal, Finding Plaintiffs Plausibly Alleged Defendants Knew Statements Summarizing FDA Meeting Were False
Life Sciences Securities Litigation ·